KRT18 and metabolic dysfunction-associated steatotic liver disease: Caspase-cleaved CK18-M30 as a specific measurement of apoptosis is a reliable noninvasive biomarker to monitor disease activity, and to evaluate the therapeutic response of patients with NAFLD (5, 35, 36).